Trial Profile
A study investigating the effect of lamivudine on HBsAg serum level in HBeAg-negative acute-on-chronic liver failure patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Lamivudine (Primary)
- Indications Liver failure
- Focus Pharmacodynamics
- 16 Dec 2015 New trial record